Auranofin/Vitamin C: A Novel Drug Combination Targeting Triple-Negative Breast Cancer - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue JNCI: Journal of the National Cancer Institute Année : 2019

Auranofin/Vitamin C: A Novel Drug Combination Targeting Triple-Negative Breast Cancer

Dates et versions

hal-02398555 , version 1 (07-12-2019)

Identifiants

Citer

Elie Hatem, Sandy Azzi, Nadine El Banna, Tiantian He, Amélie Heneman-Masurel, et al.. Auranofin/Vitamin C: A Novel Drug Combination Targeting Triple-Negative Breast Cancer. JNCI: Journal of the National Cancer Institute, 2019, 111 (6), pp.597-608. ⟨10.1093/jnci/djy149⟩. ⟨hal-02398555⟩
53 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More